Y-Mabs Therapeutics (YMAB) P/E (2018 - 2025)
Y-Mabs Therapeutics (YMAB) P/E from Oct 1, 2018 to Sep 16, 2025. The TTM Y-Mabs Therapeutics (YMAB) P/E is -17.33. You can export chart.
P/E
Annual P/E change of Y-Mabs Therapeutics (YMAB)
| Year | P/E | Change |
|---|---|---|
| 2025 | -17.33 | +48.65% |
| 2024 | -11.66 | -24.49% |
| 2023 | -15.44 | +870.40% |
| 2022 | -1.59 | -87.34% |
| 2021 | -12.57 | -24.30% |
| 2020 | -16.60 | +24.67% |
| 2019 | -13.31 | -40.64% |
| 2018 | -22.43 | N/A |
Comparison Y-Mabs Therapeutics (YMAB) P/E with competitors
Y-Mabs Therapeutics (YMAB) P/E is -17.33.